Nalaganje...
Relapse prevention in adults with major depressive disorder treated with vilazodone: a randomized, double-blind, placebo-controlled trial
This randomized withdrawal study assessed relapse prevention with vilazodone in adults with major depressive disorder. After 20 weeks of open-label treatment with vilazodone 40 mg/day, responders were randomized (1 : 1 : 1) to 28 weeks of double-blind, fixed-dose treatment with vilazodone 20 mg/day,...
Shranjeno v:
| izdano v: | Int Clin Psychopharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Lippincott Williams And Wilkins
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6166708/ https://ncbi.nlm.nih.gov/pubmed/30044247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000236 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|